BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26642816)

  • 1. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Ischemia-Modified Albumin in Patients with Inflammatory Bowel Disease.
    Guntas G; Sahin A; Duran S; Kahraman R; Duran I; Sonmez C; Calhan T; Sokmen HM
    Clin Lab; 2017 Feb; 63(2):341-347. PubMed ID: 28182340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
    Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
    Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
    Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S; Hamamoto H; Morinaga Y; Oda K; Fujita T; Arima S; Nasu Y; Sasaki F; Hashimoto S; Taguchi H; Setoyama H; Ido A
    Digestion; 2016; 93(4):300-8. PubMed ID: 27220673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide.
    Teng X; Yang Y; Liu L; Yang L; Wu J; Sun M; Xu L
    Pediatr Res; 2020 Nov; 88(5):792-795. PubMed ID: 32120375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.
    Kovacs M; Papp M; Lakatos PL; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Molnar K; Szabo D; Cseh A; Muller KE; Dezsofi A; Arato A; Veres G
    J Crohns Colitis; 2013 Mar; 7(2):134-41. PubMed ID: 22504031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease.
    Algaba A; Linares PM; Fernández-Contreras ME; Ordoñez A; Trápaga J; Guerra I; Chaparro M; de la Poza G; Gisbert JP; Bermejo F
    J Crohns Colitis; 2013 Dec; 7(11):e569-79. PubMed ID: 23642997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
    Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
    Eivindson M; Nielsen JN; Grønbaek H; Flyvbjerg A; Hey H
    Horm Res; 2005; 64(1):9-15. PubMed ID: 16088202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Peripheral Eosinophilia at Diagnosis in Children With Inflammatory Bowel Disease.
    Sadi G; Yang Q; Dufault B; Stefanovici C; Stoffman J; El-Matary W
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):573-6. PubMed ID: 26308316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
    Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
    World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
    Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
    Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.